Search Results 8241-8250 of 34405 for oral

  1. A Phase 1b/2 Study of Onvansertib (PCM-075) in Combination with FOLFIRI and Bevacizumab for Second-Line Treatment of Metastatic Colorectal Cancer in Patients with a KRAS Mutation - Mayo Clinic

    Gastrointestinal (GI) disorder(s) that, in the opinion of the Investigator, would significantly impede the absorption of an oral agent (e.g., intestinal ...

  2. Phase II Trial of Irinotecan, Cetuximab, and Bevacizumab Compared With Irinotecan, Cetuximab, and Placebo in KRAS-Wildtype, Irinotecan-Refractory, Metastatic Colorectal Cancer - Mayo Clinic

    Women who are using oral, implanted, or injectable contraceptive hormones or mechanical products such as intrauterine device or barrier methods (diaphragm ...

  3. A Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer - Mayo Clinic

    Ability to swallow oral medication. Adequate bone marrow function (Platelets ≥100x10^9/L; Absolute Neutrophil Count (ANC) ≥ 1.5x10^9/L and Haemoglobin ...

  4. Autoimmune pancreatitis - Symptoms and causes - Mayo Clinic

    You may need treatment with oral medicine or insulin. Pancreatic and bile duct narrowing, called stricture. Pancreatic calcifications or stones. Treatments ...

  5. Ivosidenib, Nivolumab, and Ipilimumab Combination in Previously Treated Subjects with Nonresectable or Metastatic IDH1-Mutant Cholangiocarcinoma - Mayo Clinic

    Inability to swallow oral medication. Pregnant and lactating women. WOCBP who tested positive in a serum pregnancy test within 24 hours prior to the first ...

  6. Efficacy And Safety Of Nemtabrutinib (MK-1026) In Participants With Hematologic Malignancies (MK-1026-003) - Mayo Clinic

    * Has the ability to swallow and retain oral medication * Participants who are Hepatitis B surface antigen (HBsAg)-positive are eligible if they have ...

  7. Randomized Trial of Pegylated Interferon Alfa-2a Versus Hydroxyurea in Polycythemia Vera (PV) and Essential Thrombocythemia (ET) - Mayo Clinic

    No concurrent hormonal oral contraceptive use. Exclusion Criteria: (ANY of the following, both strata). Known to meet the criteria for primary myelofibrosis ...

  8. Myomectomy - Doctors & Departments - Mayo Clinic

    Oral gonadotropin-releasing hormone antagonists for the treatment of uterine leiomyomas. Obstetrics & Gynecology. 2023; doi:10.1097/AOG.0000000000005145 ...

  9. Myomectomy - Doctors & Departments - Mayo Clinic

    Oral gonadotropin-releasing hormone antagonists for the treatment of uterine leiomyomas. Obstetrics & Gynecology. 2023; doi:10.1097/AOG.0000000000005145 ...

  10. Tuesday Q and A: Intermittent swelling in jaw should be evaluated - Mayo Clinic News Network

    Your salivary glands make saliva. Saliva aids in digestion and keeps your mouth moist. You have three pairs of major salivary glands under and behind your jaw — ...